Nepal approves use of ‘covishield vaccine’ against COVID-19

KATHMANDU: The Department of Drug Administration (DoA) has given approval to the use of covishield vaccine against COVID-19 in Nepal.

The covishield vaccine is developed by Serum Institute of India.

“Conditional permission has been granted for emergency use authorization of covishield vaccine against COVID-19 as per the decision of the department,” reads a press statement issued by DoA) today.